Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8722650 | BAUSCH | Extended-release minocycline dosage forms |
Jun, 2025
(1 year, 8 months from now) | |
US8252776 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(1 year, 8 months from now) | |
US8268804 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(1 year, 8 months from now) | |
US7790705 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(1 year, 8 months from now) | |
US7919483 | BAUSCH | Method for the treatment of acne |
Mar, 2027
(3 years from now) | |
US7544373 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Apr, 2027
(3 years from now) | |
US7541347 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Apr, 2027
(3 years from now) | |
US9192615 | BAUSCH | Method for the treatment of acne and certain dosage forms thereof |
Nov, 2031
(8 years from now) |
Solodyn is owned by Bausch.
Solodyn contains Minocycline Hydrochloride.
Solodyn has a total of 8 drug patents out of which 0 drug patents have expired.
Solodyn was authorised for market use on 08 May, 2006.
Solodyn is available in tablet, extended release;oral dosage forms.
Solodyn can be used as treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris, treatment of acne.
The generics of Solodyn are possible to be released after 17 November, 2031.
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Market Authorisation Date: 08 May, 2006
Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris
Dosage: TABLET, EXTENDED RELEASE;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic